opportunities for electrical neuromodulation of respiratory ......metaproterenol (1.5 µg) 25 (90...

21
Opportunities for Electrical Neuromodulation of Respiratory Function Marian Kollarik The Johns Hopkins University School of Medicine, Baltimore, MD

Upload: others

Post on 04-Mar-2021

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Opportunities for Electrical Neuromodulation of Respiratory Function

Marian Kollarik The Johns Hopkins University School of Medicine, Baltimore, MD

Page 2: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Nerves play a major role in pathophysiology of respiratory diseases (asthma, COPD).

The lung is a very feasible target for peripheral neuromodulation.

Additional functional and anatomical mapping will enable more refined neuromodulation strategies.

Page 3: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

3

Page 4: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

RESPIRATORY SYSTEM

NERVES

COUGH

MUCUS SECRETION DYSPNEA

BRONCHOSPASM

Page 5: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Neural regulation of the lung is mediated by vagus nerves

Jugular

5

Page 6: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Reflexes: • Airway smooth muscle constriction

• Secretions

Sensations: • Dyspnea • Cough

6

Page 7: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Parasympathetic regulation of airway smooth muscle

Medulla

Preganglionic (vagus nerve)

Parasympathetic ganglia

Postganglionic

+ acetyl- - VIP choline NO

Airway smooth muscle

Human bronchus

Page 8: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Reversible Airways Obstruction in COPD is DependentUpon Parasympathetic Cholinergic Nerves

30

* * Metaproterenol (1.5 µg)

25 (90 Patients)

Ipratropium Bromide (36 µg) 20 (107 Patients)

15

10

5

0

*

*

*

*

*

0 60 120 180 240 300 360

ME

AN

FE

V1,

% C

HA

NG

E

Minutes After Treatment

(Modified from Tashkin et al. 1986)

Page 9: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Tht NEW ENGLAN D J OU RNAL of MEOTC INE

[_I_________o_R_ 1G_ 1N_ A_L_A_R_T_1c__L_E__________,I[

Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma

--

--

--

so

40

.... _

... c 30 a.. ­ooE ·-c-

~ 20E ., 0 "' ::IE""" 10

0

- 10

P=0.26

P<0.001

P<0.001

____ ..___ _,

Tiotropium Double­ Salmeterol Glucocorticoid

so

40

... _ 30

~ .E .. E .E ~ 20

... c -.. 10 ~~

-1:

P..().05

P<0.001

P<0.001

-----------.,.----Tiotropium Oouble­ Salmet>!rol

Glucocor'licoid

Page 10: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Reflexes: • Airway smooth muscle constriction

• Secretions

Sensations: • Dyspnea • Cough

10

Page 11: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Afferent nerve subtypes in the large airways

cough receptor C-fiibers

acid pH=6

(Kollarik & Undem 2002; Canning, 2004)

Page 12: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Afferent nerve subtypes in the large airways

CA B

FD E

Mice and Rats Guinea Pigs Humans

Page 13: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Afferent innervation of the lung

Rat, In vivo, adapted from (Lee et al. 2003)

0

30

Bronchopulmonar y C-fibers

Pt

nerve activity

5 s

lung

infla

tion

A-fiber stretch mechanoreceptors

n=109 n=96

RAR SAR nodose C-fibers

jugular C-fibers

mice, rats, guinea pigs, rabbits, cats, dogs

Page 14: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Bronchopulmonary C-fibers

• relatively quiescent in normal tissue

• readily stimulated by noxious chemicals, inflammatory mediators or excessive physical stimuli

capsaicin 01µM

C-fiber activators initiate cough in humans and animal models

• Capsaicin (TRPV1) • Cinnamaldehyde (TRPA1) • Citric Acid (TRPV1/ASIC) • Bradykinin (B2) • Water (?)

Reviewed in (Coleridge et al., 1984; Lee et al., 2001; Canning 2009).

Page 15: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Central neural circuitry regulating the parasympathetic innervation of the airways

C-fibers

RAR and SAR stretch A-fiber mchanoreceptors

Afferent Efferent

Page 16: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Inflammation-induced neuroplasticity

Reflexes: • Airway smooth muscle constriction

• Secretions

Sensations: • Dyspnea • Cough

Page 17: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

In vivo transfection of sensory nerves with AAV virus vectors

In injection into sensory ganglia

Kollarilk et al., J Physiol 2010

Page 18: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Vagal afferent nerve terminals in the trachea

Page 19: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Knockdown of Nav 1.7 expression and function by AAV-delivered shRNA

ctrl shRNA

Nav 1.7 shRNA

Muroi Y, Ru F, Kollarik M, Canning BJ, Hughes SA, Walsh S, Sigg M, Carr MJ, Undem BJ. J Physiol. 2011*

**

Page 20: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Recording from human vagal pulmonary branches – ex vivo optimization of stimulation parameters

CTRL WASH (>3h)

C-wave

Cmpd X (Nav1.7 blocker) 1µM

Isolated branch of the vagus nerve (≈25 mm)

stimulate

record

*

Kollarik, unpublished.

Page 21: Opportunities for Electrical Neuromodulation of Respiratory ......Metaproterenol (1.5 µg) 25 (90 Patients) 20 Ipratropium Bromide (36 µg) (107 Patients) 15 10 5 0 * * * * * 0 60

Nerves play a major role in pathophysiology of respiratory diseases (asthma, COPD).

The lung is a very feasible target for peripheral neuromodulation.

Additional functional and anatomical mapping will enable more refined neuromodulation strategies.